A Phase 2, Randomized Clinical Study of Intravenous or Intratumoral Administration of V937 in Combination with Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants with Advanced/Metastatic Melanoma

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann, (Project Manager)
  • Khattak, Adnan (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date12/12/19 → 31/12/22
View all
View less

Keywords

  • Metastatic Melanoma
  • Medical oncology
  • Clinical trial